GlassScriptPhysician profile
Garwin Chin
NPI 1215424452
$44,210.06
in general payments reported to CMS, 2019-2025
10 companies · $2,572 in 2025
The $2,572 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $1,521 · 2023: $30K · 2024: $10K · 2025: $2,572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $32K · Education: $4,321 · Travel and Lodging: $3,316 · Food and Beverage: $3,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $31,666.67 |
| Education | $4,321.20 |
| Travel and Lodging | $3,316.26 |
| Food and Beverage | $3,278.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $23,088.80 | 2023-2025 | |
| Smith+Nephew, INC. | $8,591.62 | 2023-2025 | Q-Fix, Spatial Frame |
| Djo, LLC | $7,500.00 | 2023-2024 | |
| Stryker Corporation | $2,604.64 | 2022-2025 | Salvation, Axsos, Iconix |
| Encore Medical, LP | $1,407.06 | 2024 | Djo Surgical |
| Vital Orthopedics LLC | $583.17 | 2025 | |
| Ossur Americas, INC. | $290.70 | 2024 | Miami J |
| Microport Orthopedics INC | $106.02 | 2021 | |
| Globus Medical, INC. | $21.74 | 2023 | Ankle Fracture System |
| Medacta USA, INC. | $16.31 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garwin Chin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.